%0 Journal Article
%T Stereotactic body radiation therapy for pulmonary large cell neuroendocrine carcinoma: a case report
%A In Young Jo
%A Seung-Gu Yeo
%J Archive of "OncoTargets and therapy".
%D 2019
%R 10.2147/OTT.S189858
%X The incidence of large cell neuroendocrine carcinoma (LCNEC) of the lung is rare, and the treatment methods and prognosis for such patients are still subjects of debate. We report a case of a 78-year-old male LCNEC patient for whom stereotactic body radiation therapy was performed. A four-dimensional computed tomography scan was used for simulation, and radiotherapy was planned using the volumetrically modulated arc technique. A total of 55 Gy was delivered in five daily fractions. The treatment was safely completed, and the patient did not report any discomfort. The only side-effect was an intermittent cough. Currently, the patient has received 18 months of outpatient follow-up care with no evidence of disease. In conclusion, stereotactic body radiation therapy can be a valuable treatment option for early stage LCNEC
%K lung
%K large cell
%K neuroendocrine carcinoma
%K stereotactic ablative radiotherapy
%K radiation therapy
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388991/